Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
980.3 DKK | +1.34% |
|
+0.65% | +40.42% |
Jul. 12 | Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market | RE |
Jul. 12 | Ozempic linked with lower dementia risk, nicotine use, British study finds | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.42% | 636B | |
+62.66% | 854B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B | |
+5.17% | 129B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- NOVO NORDISK : Deutsche Bank remains its Buy rating